Allergy Disease R&D Company Lycia Therapeutics Expands Fundraising Scale and Is Set to List on Nasdaq Life Science
Gilead Sciences Bolsters Inflammation Pipeline as Multiple New Drugs Support Performance Life Science
UnitedHealth Earnings Rebound Stronger Than Expected, Investors Focus on Sustainability of Recovery Life Science
Market Volatility Highlights Allocation Value as Two Pharmaceutical Dividend Stocks Face Market Scrutiny Life Science
AstraZeneca and Oracle AI Trial Pact: Can the Partnership Reset the Market’s Pricing? Life Science, Technology
Weight Loss Drug Market Continues to Expand as Regeneron’s Two Candidate Drugs Demonstrate Differentiated Potential Life Science
Johnson & Johnson Raises Full-Year Sales Forecast, Annual Revenue Poised to Exceed $100 Billion for First Time Life Science
